References
- Gouriet F, Chaudet H, Gautret P, Pellegrin L, de Santi VP, Savini H, et al. Endocarditis in the Mediterranean Basin. New Microbes New Infect. 2018;26:S43–S51.
- Pallotto C, Martinelli L, Baldelli F, Bucaneve G, Cecchini E, Malincarne L, et al. Trends in infective endocarditis in a medium-sized University Hospital in Italy: analysis of 232 cases. Infez Med. 2014;22(2):124–31.
- Habib G, Erba PA, Lung B, Donal E, Cosyns B, Laroche C, et al. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J. 2019; 40(39):3222–3232.
- Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta J-P, Del Zotti F, et al. 2015 ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM)). Eur Heart J. 2015;36(44):3075–128.
- Baddour LM, Wilson WR, Bayer AS, Fowler VG, Tleyjeh IM, Rybak MJ, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132(15):1435–86.
- Cooper MD, Keeney RE, Lyons SF, Cheatle EL. Synergistic effects of ampicillin-aminoglycoside combinations on group B Streptococci. Antimicrob Agents Chemother. 1979;15(3):484–6.
- Baker CN, Thornsberry C, Facklam RR. Synergism, killing kinetics, and antimicrobial susceptibility of group A and B streptococci. Antimicrob Agents Chemother. 1981;19(5):716–25. 5.716.
- Swingle HM, Bucciarelli RL, Ayoub EM. Synergy between penicillins and low concentrations of gentamicin in the killing of group B streptococci. J Infect Dis. 1985;152(3):515–20.
- Ruppen C, Lupo A, Decosterd L, Sendi P. Is penicillin plus gentamicin synergistic against clinical group B Streptococcus isolates? An in vitro study. Front Microbiol. 2016;7:1680.
- Gagneux-Brunon A, Pouvaret A, Maillard N, Berthelot P, Lutz MF, Cazorla C, et al. Acute kidney injury in infective endocarditis: a retrospective analysis. Méd Mal Infect. 2019;49(7):527–33.
- Tascini C, Di Paolo A, Poletti R, Flammini S, Emdin M, Ciullo I, et al. Daptomycin concentrations in valve tissue and vegetation in patients with bacterial endocarditis. Antimicrob Agents Chemother. 2013;57(1):601–2.
- Sader HS, Flamm RK, Farrell DJ, Jones RN. Daptomycin activity against uncommonly isolated streptococcal and other gram-positive species groups. Antimicrob Agents Chemother. 2013; 57(12):6378–80.
- García-de-la-Mària C, Pericas JM, Del Río A, Castañeda X, Vila-Farrés X, Armero Y, et al. Early in vitro and in vivo development of high-level daptomycin resistance is common in mitis group streptococci after exposure to daptomycin. Antimicrob Agents Chemother. 2013;57(5):2319–25..
- Akins RL, Katz BD, Monahan C, Alexander D. Characterization of high-level daptomycin resistance in viridans group streptococci developed upon in vitro exposure to daptomycin. Antimicrob Agents Chemother. 2015;59(4):2102–12..
- Yim J, Smith JR, Singh NB, Rice S, Stamper K, Garcia de la Maria C, et al. Evaluation of daptomycin combinations with cephalosporins or gentamicin against Streptococcus mitis group strains in an in vitro model of simulated endocardial vegetations (SEVs). J Antimicrob Chemother. 2017;72(8):2290–6.
- Tascini C, Aimo A, Arzilli C, Sbrana F, Ripoli A, Ghiadoni L, et al. Procalcitonin, white blood cell count and C-reactive protein as predictors of S. aureus infection and mortality in infective endocarditis. Int J Cardiol. 2020;301:190–4.
- Akins RL, Barber KE, Palmer KL. Pronounced heterogeneity observed in high-level daptomycin-resistant viridans group streptococci. J Glob Antimicrob Resist. 2016;7:159–66.
- Tascini C, Sbrana F, Sozio E, Dal Pino B, Bertolino G, Ripoli A, Pallotto C, Emdin M, Sampietro T. Statins during daptomycin therapy: to give or not to give? Minerva Anestesiol. 2019;85(6):689–90.